Reprogramming bladder cancer cells for studying cancer initiation and progression

Area of Science:

• Stem Cell Biology
• Oncology
• Molecular Biology

Background:

• Induced pluripotent stem cell (iPSC) technology involves reprogramming somatic cells into pluripotent stem cells.
• Reprogramming cancer cells into iPSCs is challenging due to genetic and epigenetic barriers, with limited success in specific cancer types.
• Bladder cancer presents a significant health concern, necessitating novel research avenues.

Purpose of the Study:

• To investigate the reprogramming efficiency of two bladder cancer cell lines (HTB-9 and T24) into iPSC-like cells.
• To explore the potential of using iPSC technology for bladder cancer research and therapeutic development.
• To characterize the properties of reprogrammed bladder cancer cells.

Main Methods:

• Utilized non-integrating Sendai virus (SeV) for reprogramming.
• Employed a combination of four key transcription factors (OCT4, SOX2, KLF4, c-MYC) – referred to as 4Fs.
• Generated six sub-clones from HTB-9 and T24 bladder cancer cell lines.

Main Results:

• Only one sub-clone, T24 cells transduced with 4Fs (T24 4F cells), successfully generated iPSC-like cells.
• T24 4F cells exhibited key pluripotent cell characteristics, including epithelial-like morphology, colony formation, expression of pluripotency markers, and in vitro differentiation capacity.
• This study is the first to report on the reprogramming susceptibility of these specific bladder cancer cell lines.

Conclusions:

• Nuclear reprogramming of bladder cancer cells is feasible, albeit with cell-type specificity.
• Reprogrammed T24 4F cells offer a novel platform for investigating bladder cancer biology and carcinogenesis.
• These iPSC-like cells hold promise as a valuable tool for developing innovative therapeutic strategies for bladder carcinoma.